Side-by-side comparison of AI visibility scores, market position, and capabilities
New Orleans Gulf South regulated utility (NYSE: ETR) ~$12B revenue; 1,500 MW new gas gen for Meta data center (Entergy Louisiana), nuclear baseload, Mississippi River industrial corridor competing with Cleco.
Entergy Corporation is a New Orleans, Louisiana-based regulated electric utility holding company — publicly traded on the New York Stock Exchange (NYSE: ETR) as an S&P 500 Utilities component — providing electricity generation, transmission, and distribution to approximately 3 million customers across Arkansas, Louisiana, Mississippi, and Texas through four regulated utility subsidiaries: Entergy Arkansas, Entergy Louisiana, Entergy Mississippi, and Entergy Texas, along with Entergy New Orleans, through approximately 13,000 employees. Entergy Louisiana broke ground in 2025 on two new combined-cycle natural gas combustion turbine plants totaling approximately 1,500 megawatts of generation capacity in Richland Parish, Louisiana — directly supporting Meta's new data center development in the region — representing one of the largest generation investments in Entergy Louisiana's recent history, with the facilities projected to save customers $650 million through 2040 through more efficient power generation displacing higher-cost units. CEO Drew Marsh leads Entergy's strategy of executing on the unprecedented data center and industrial load growth in Louisiana, where the combination of affordable land, available water for cooling, reliable power infrastructure, and the Mississippi River industrial corridor creates favorable economics for hyperscale data center siting. Entergy's nuclear fleet (Grand Gulf Nuclear Station in Mississippi, Arkansas Nuclear One, Waterford 3 in Louisiana, River Bend Station in Louisiana) provides low-carbon baseload power that supports Entergy's reliability obligations and serves data center customers' clean energy procurement preferences.
Global pharma company with $55B 2024 revenue; successfully diversifying beyond Humira with Skyrizi, Rinvoq, and $8.7B Cerevel neuroscience acquisition.
AbbVie is a global research-based biopharmaceutical company focused on developing treatments for complex and serious diseases including immunology, oncology, neuroscience, aesthetics, and eye care. Spun off from Abbott Laboratories in 2013 and headquartered in North Chicago, Illinois, AbbVie rapidly became one of the world's top pharmaceutical companies on the strength of Humira — the world's best-selling drug for over a decade with peak annual sales exceeding $20 billion. AbbVie is listed on the NYSE and is a component of the S&P 500 and Dow Jones Industrial Average.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.